03/18/2015 I hope I am not inundating you with too many of these “Email Blasts.” However, once again, there is an article on the front page of the NY Times, which I feel mandates some commentary by me. And once again, I have gone back to the original article, which appears in the current issue of JAMA (Journal of the American Medical Association) rather than just the NY Times rendition and summary of it. The article is entitled “Diagnostic Concordance Among Pathologists Interpreting Br...
2/17/2015 In today’s NY Times a story on the front page has the headline “Up To 14 Years of Hot Flashes Found in Menopause Study”. I agree totally. In my years of practice I have had many patients, some who resist therapy, and some unable to get off Hormone Replacement Therapy (HRT) who have symptoms even longer than that! I went to the original article published yesterday in the Journal of the American Medical Association (JAMA). This is still another report from a study called SWAN (Stu...
3/13/2014 Some of you may have seen an article on the front page of the business section of the New York Times today entitled “FDA Panel Recommends Replacement for the Pap Test.” Understand that this is simply an Advisory Committee to the FDA and this recommendation may or may not be adopted by the FDA itself. Furthermore, as pointed out in the article, this does not mean that various societies like the American College of Obstetricians and Gynecologists will automatically change their guid...
9/16/2013 Lately it seems that I have had a large number of patients with daughters “coming of age”. As a result I am recycling something I wrote a while back but may be even more pertinent today. When should your daughter first visit the gynecologist? I love to be a teenager’s first gynecologist. It does not have to be a traumatic experience. A positive first visit will ensure that she is not “ruined” as a gynecologic patient. Even if her next several doctors in a row are...
7/30/2013 The lead story in today’s New York Times, on the right hand column of Page One, is entitled “Scientists Urge Narrower Rules to Define Cancer”. The main thesis of the article, which chronicles a study published yesterday in the Journal of the American Medical Association, is something I have been saying to many of you for quite some number of years. Perhaps the following anecdote will underscore the issue: Several years ago a patient came to me for a routine visit. When I a...
04/16/2013 In today’s New York Times (Tuesday April 16, 2013) there’s an article by Denise Grady which reports recommendations of the United States Preventive Services Task Force (USPSTF) who published a draft form of their recommendations for public comment concerning the drugs raloxifene (Evista) and tamoxifen (Nolvadex). As many of you are aware, I have published extensively on these drugs and participated in studies for both. Tamoxifen has been used for several decades, initially for wo...
Many of you may have seen the article in the New York Times and other news media outlets relative to the breast cancer drug tamoxifen. As many of you know, I was involved in the STAR trial which compared tamoxifen and raloxifene for breast cancer prevention. Much of my academic work has been involved in the ultrasound appearance of the uterus in patients receiving tamoxifen therapy. I've had a long standing interest in the treatment of estrogen receptor positive breast cancers and selective...
THIS WEBSITE DOES NOT PROVIDE MEDICAL ADVICE
The information on this site (or blog or article) is not a substitute for in office medical advice, diagnosis or treatment. The information is provided for informational or educational purposes only
